HomeNewsBusinessNet employee addition in top 3 IT firms declines YoY in FY20

Net employee addition in top 3 IT firms declines YoY in FY20

The decline was sharper for Infosys at 40 percent, followed by TCS at 17 percent and Wipro at 3 percent.

April 21, 2020 / 21:48 IST
Story continues below Advertisement

Net employee additions in top three IT majors – Tata Consultancy Services (TCS), Wipro and Infosys – has seen an average decline of 20 percent in FY20 compared to FY19.

The decline was sharper for Infosys at 40 percent, followed by TCS at 17 percent and Wipro at 3 percent. For the year-ended March, Infosys added 14,248 people last fiscal as opposed to 24,013 in FY19.

Story continues below Advertisement

In the case of TCS, net addition stood at 24,179 in FY20 compared to 29,287 in FY19.

For Wipro, hiring doubled in FY20. The company recruited 12,000 freshers. However, net additions stood at 11,461 in FY20 versus 11,502 people in FY19.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show